Already 15 years ago CD4+ Th cells of the Th1 (predominantly IFNγ) and Th2 (predominantly IL-4) cells as well as CD8+ T cells have been shown to play a key role for an effective anti-tumor response. Here, CD8A is linked to neoplasm.